CEOINSIDER
Hoffmann-La Roche logo

Company

Hoffmann-La Roche

PrivateSwitzerland

F. Hoffmann-La Roche is a Swiss multinational pharmaceutical and diagnostics company that develops and manufactures drugs and healthcare solutions.

Hoffmann-La Roche is a privately held company, based in Switzerland. Leadership tracked by CEOInsider includes Thomas Schinecker (CEO).

www.roche.com ↗LinkedIn ↗

Leadership

Current

Recent developments

AI summary of recent coverage

Recent coverage of Hoffmann-La Roche has focused on significant capital investments and strategic initiatives, including a major $50 billion commitment to pharmaceutical and diagnostics operations in the United States and the acquisition of 89bio for $2.4 billion. The company has also made leadership changes to its executive committee, opened new research facilities, and pursued efforts to address tariff impacts through government discussions. Additionally, coverage has highlighted strong financial performance and the company's positioning for continued growth in the pharmaceutical sector.

Summarized from the headlines in the sidebar; see each source for the full story.